AfrikaansazərbaycancatalàČeštinaDanskDeutscheestiEnglish (United Kingdom)English (United States)Español (España)Español (Latinoamérica)euskaraFilipinoFrançais (Canada)Français (France)galegoHrvatskiIndonesiaisiZuluíslenskaItalianoKiswahililatviešulietuviųmagyarMelayuNederlandsnorskpolskiPortuguês (Brasil)Português…
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth’s OptumRx unit will not be renewed after they expire in June.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Biocon is developing a generic version of Novo Nordisk’s Wegovy and is prepared to conduct a clinical trial next year if needed.
BIO’s about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and…
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
Access Google Forms with a personal Google account or Google Workspace account (for business use).
Access Google Forms with a personal Google account or Google Workspace account (for business use).
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week…
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
